EGFR and cancer: Recent studies have also found that miR-34a can down-regulate Wnt/β-catenin signaling pathway, epidermal growth factor receptor, caspase family-associated protein and EMT in various cancer tissues and inhibit cell proliferation, promote apoptosis and inhibit metastasis.